(ATEX) Anterix - Overview
Stock: Spectrum Licensing, Private Broadband, CatalyX Platform
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 55.4% |
| Relative Tail Risk | -14.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.16 |
| Alpha | -13.14 |
| Character TTM | |
|---|---|
| Beta | 0.714 |
| Beta Downside | 0.838 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.35% |
| CAGR/Max DD | -0.11 |
Description: ATEX Anterix December 26, 2025
Anterix Inc. (NASDAQ:ATEX) commercializes licensed 900 MHz spectrum to enable utilities and critical-infrastructure operators to build private broadband networks, positioning itself as a niche provider of dedicated connectivity solutions.
The firm’s product suite includes the CatalyX ecosystem platform, supplemental spectrum bundles, the Anterix Security Collective, and rural broadband services, all aimed at delivering secure, low-latency connectivity for mission-critical applications.
Holding nationwide 900 MHz licenses-including coverage of the contiguous United States, Hawaii, Alaska, and Puerto Rico-Anterix leverages a spectrum asset base that is scarce and increasingly valuable as enterprises seek alternatives to congested mid-band and millimeter-wave bands.
Key metrics (as of the latest 10-Q) show a modest revenue growth of ~12% YoY, with an average contract length of 5 years, indicating relatively stable cash flows; the company’s market-share of private-network deployments remains under 5%, suggesting significant upside potential if adoption accelerates. A primary sector driver is the rising regulatory push for dedicated broadband in the energy and transportation sectors, while macro-economic factors such as capital-expenditure cycles in utilities will directly affect demand for Anterix’s services.
For a deeper, data-driven assessment of Anterix’s valuation dynamics, you might explore the analytical tools available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: 95.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -14.17 > 1.0 |
| NWC/Revenue: 408.2% < 20% (prev 730.6%; Δ -322.5% < -1%) |
| CFO/TA -0.06 > 3% & CFO -26.0m > Net Income 95.6m |
| Net Debt (-34.3m) to EBITDA (29.0m): -1.19 < 3 |
| Current Ratio: 1.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.7m) vs 12m ago 0.64% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 1.61% > 50% (prev 1.77%; Δ -0.16% > 0%) |
| Interest Coverage Ratio: -0.39 > 6 (EBITDA TTM 29.0m / Interest Expense TTM -72.8m) |
Altman Z'' -3.37
| A: 0.06 (Total Current Assets 58.8m - Total Current Liabilities 34.6m) / Total Assets 420.4m |
| B: -0.75 (Retained Earnings -314.2m / Total Assets 420.4m) |
| C: 0.08 (EBIT TTM 28.5m / Avg Total Assets 368.8m) |
| D: -1.75 (Book Value of Equity -314.2m / Total Liabilities 180.0m) |
| Altman-Z'' Score: -3.37 = D |
Beneish M -2.91
| DSRI: 0.79 (Receivables 10.0m/12.1m, Revenue 5.92m/5.61m) |
| GMI: 0.91 (GM 95.51% / 87.11%) |
| AQI: 1.06 (AQ_t 0.85 / AQ_t-1 0.80) |
| SGI: 1.06 (Revenue 5.92m / 5.61m) |
| TATA: 0.29 (NI 95.6m - CFO -26.0m) / TA 420.4m) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of ATEX shares?
Over the past week, the price has changed by +8.09%, over one month by +24.41%, over three months by +57.81% and over the past year by -0.73%.
Is ATEX a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ATEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.3 | 94.9% |
| Analysts Target Price | 55.3 | 94.9% |
| ValueRay Target Price | 30.6 | 7.6% |
ATEX Fundamental Data Overview February 03, 2026
P/S = 83.0718
P/B = 2.0473
Revenue TTM = 5.92m USD
EBIT TTM = 28.5m USD
EBITDA TTM = 29.0m USD
Long Term Debt = 4.73m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.43m USD (from shortTermDebt, last quarter)
Debt = 4.73m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -34.3m USD (from netDebt column, last quarter)
Enterprise Value = 457.9m USD (492.2m + Debt 4.73m - CCE 39.1m)
Interest Coverage Ratio = -0.39 (Ebit TTM 28.5m / Interest Expense TTM -72.8m)
EV/FCF = -15.24x (Enterprise Value 457.9m / FCF TTM -30.0m)
FCF Yield = -6.56% (FCF TTM -30.0m / Enterprise Value 457.9m)
FCF Margin = -506.9% (FCF TTM -30.0m / Revenue TTM 5.92m)
Net Margin = 1614 % (Net Income TTM 95.6m / Revenue TTM 5.92m)
Gross Margin = unknown ((Revenue TTM 5.92m - Cost of Revenue TTM 266.0k) / Revenue TTM)
Tobins Q-Ratio = 1.09 (Enterprise Value 457.9m / Total Assets 420.4m)
Interest Expense / Debt = 1239 % (Interest Expense 58.6m / Debt 4.73m)
Taxrate = 12.31% (7.52m / 61.1m)
NOPAT = 25.0m (EBIT 28.5m * (1 - 12.31%))
Current Ratio = 1.70 (Total Current Assets 58.8m / Total Current Liabilities 34.6m)
Debt / Equity = 0.02 (Debt 4.73m / totalStockholderEquity, last quarter 240.3m)
Debt / EBITDA = -1.19 (Net Debt -34.3m / EBITDA 29.0m)
Debt / FCF = 1.14 (negative FCF - burning cash) (Net Debt -34.3m / FCF TTM -30.0m)
Total Stockholder Equity = 181.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 25.93% (Net Income 95.6m / Total Assets 420.4m)
RoE = 52.66% (Net Income TTM 95.6m / Total Stockholder Equity 181.6m)
RoCE = 15.29% (EBIT 28.5m / Capital Employed (Equity 181.6m + L.T.Debt 4.73m))
RoIC = 13.75% (NOPAT 25.0m / Invested Capital 181.6m)
WACC = 8.47% (E(492.2m)/V(496.9m) * Re(8.55%) + (debt cost/tax rate unavailable))
Discount Rate = 8.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.56%
Fair Price DCF = unknown (Cash Flow -30.0m)
EPS Correlation: 57.16 | EPS CAGR: 34.56% | SUE: 0.47 | # QB: 0
Revenue Correlation: 93.29 | Revenue CAGR: 45.03% | SUE: 0.73 | # QB: 0
EPS next Year (2027-03-31): EPS=-2.10 | Chg30d=-0.409 | Revisions Net=+2 | Growth EPS=-142.3% | Growth Revenue=+7.5%